Journal of Public Health and Preventive Medicine: Announcements
Journal: Journal of Public Health and Preventive Medicine ISSN: 3068-9376 Publisher: Public Health Young Scholars Alliance (PHYSA) Frequency: Monthly Open Access: Yes (CC BY 4.0)
Notice of Article Processing Charge (APC) Waiver
To the Global Research Community,​​ In our continued commitment to advance Open Access publishing, reduce barriers to knowledge dissemination, and encourage the widespread sharing of high-quality research, the editorial office of ​​[Frontiers in Preventive Medicine]​​ is pleased to announce a special initiative: ​​All Article Processing Charges (APCs) will be completely waived​​ for articles accepted for publication ​​until December 30, 2026​​. During this period, all manuscripts that successfully pass our standard peer-review process and are accepted will qualify for this waiver. No publication fees will be charged to the authors. We affirm that this APC waiver will in no way compromise the journal's rigorous peer-review standards, editorial processing, or publication quality. We take this opportunity to warmly invite researchers worldwide to submit your outstanding work. Join us in making your research freely available to a global audience and contributing to a more open and inclusive scholarly community. Best regards, ​​The Editorial Office​​
Journal of Public Health and Preventive Medicine
I. Journal Orientation and Mission This journal focuses on academic innovation and practical application in the fields of preventive medicine and public health, and is committed to building an open, inclusive, and high-quality international academic exchange platform. Its core missions include: promoting cross-regional and interdisciplinary research cooperation to facilitate the dissemination of cutting-edge theories, technical methods, and practical achievements; providing a fair platform for scholars worldwide, especially young researchers, to voice their ideas and accelerating the cultivation of disciplinary talents; serving the formulation of public health policies and the optimization of industry practices, and contributing academic strength to enhancing global health security capabilities. II. Core Principles for Development and Operation Academic Quality First: Strictly adhere to academic standards, establish a fair, transparent, and efficient peer review mechanism, and conduct rigorous review of the scientificity, innovation, and practicality of manuscripts to ensure the academic value and credibility of published achievements. Open Access Orientation: Article Processing Charges (APC) will be fully waived for manuscript submissions until December 2026 (extended from the initial phase). We will continue to optimize the fee policy in the future to minimize barriers to academic dissemination. All published articles will be assigned unique DOIs through the Crossref GME Program, supporting global academic retrieval and citation to ensure the accessibility of research results. Standardized and Compliant Operation: The journal will operate in strict accordance with international academic publishing guidelines and relevant laws and regulations, adhere to the principles of originality and authenticity, firmly resist academic misconduct, and maintain the order of academic publishing. Meeting Scholars' Needs: Focus on the core demands of researchers, optimize the overall experience of manuscript submission, review, and publication processes, provide clear author guidelines and timely communication feedback, and create a humanized academic publishing service. III. Explanation of Access Channels Manuscript Publication and Retrieval: After a manuscript is reviewed and accepted, it will be officially published on the journal's official platform and simultaneously included in the Crossref database. It will support retrieval and query through major academic search tools such as Google Scholar and Web of Science (the specific progress of inclusion will be publicly announced in real time). Journal Access Methods: Readers can freely access published academic papers through the journal's official website (https://fpmjournal.org), and cooperative databases to achieve open sharing of academic resources. Access to Dynamic Information: Updates on manuscript calls, column settings, inclusion progress, and other information about the journal will be promptly released through official FPM jorranl Website, the journal's Facebook official account, and cooperative academic platforms. We welcome your attention. IV. Validity of the Announcement and Contact Information This announcement shall take effect from the date of issuance. The journal will timely optimize relevant rules based on disciplinary development and operational practices, and any adjustments will be publicly announced in advance through official channels. For questions or suggestions regarding the journal's development, access, and operation, please contact us through the following methods: Official Email: info@fpmjournal.org Alliance Platform: Public Health Young Scholars Alliance (PHYSA) Official Website (https://physa.dpdns.org/) We would like to express our gratitude to colleagues in the global academic community for their attention and support to Frontiers in Preventive Medicine. We look forward to working with all sectors to jointly build an internationally influential academic brand in the field of preventive medicine and empower the development of public health initiatives! Hereby announced. Editorial Office of Frontiers in Preventive Medicine Public Health Young Scholars Alliance (PHYSA) October 31, 2025
Journal: Frontiers in Preventive Medicine Publisher: Public Health Young Scholars Alliance 1. Copyright Policy Upon article acceptance, the copyright of the article is transferred to Frontiers in Preventive Medicine, published by the Public Health Young Scholars Alliance. Authors retain significant rights to use and share their own work, as detailed in the "Author Rights" section below. 2. Licensing Policy All articles published in Frontiers in Preventive Medicine are made freely available under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This means that anyone is free to: Share — copy and redistribute the material in any medium or format for any purpose, including commercial use. Adapt — remix, transform, and build upon the material for any purpose, including commercial use. The license is granted under the following condition: Attribution — You must give appropriate credit to the original work, provide a link to the CC BY 4.0 license, and indicate if any changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. No additional restrictions may be applied that legally or technologically restrict others from doing anything the CC BY 4.0 license permits. 3. Copyright Notice The copyright year for each article is determined by its individual publication date (i.e., the date it is formally published online). A typical copyright notice on the PDF of an article should appear as: “© [Year] Frontiers in Preventive Medicine. Published by the Public Health Young Scholars Alliance. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).” 4. Author Rights Notwithstanding the transfer of copyright to the journal, authors are granted the following rights without requiring further permission: To reuse their article, in whole or in part, in their own future works, such as books, lectures, and conference presentations. To distribute copies of their published article (including via email or their institutional repository). To post the final, published version of their article (PDF) on their personal website, institutional repository, or any other preferred platform, immediately upon publication.
Thank you for choosing Frontiers in Preventive Medicine ( FPM，ISSN: 3068-3376 ) as a platform to share your research. To ensure a smooth submission, review, and publication process, we kindly ask you to read and follow the guidelines below carefully. 1. Scope of Submission FPM focuses on preventive medicine and public health with a global perspective. We welcome submissions of original research, reviews, case reports, and viewpoints that align with (but are not limited to) the following themes: Epidemiology and disease prevention (e.g., infectious disease control, chronic disease intervention) Health promotion and behavioral intervention (e.g., health education, lifestyle guidance) Environmental and occupational health (e.g., impact of environmental pollutants, occupational protection) Global health and health equity (e.g., cross-regional health resource allocation, vulnerable population health security) Health policy and system research (e.g., public health policy formulation, healthcare system optimization) Digital health and innovative prevention (e.g., AI in disease prediction, telehealth management) 2. Manuscript Types & Requirements 2.1 Original Research Content: Present novel, rigorous research findings (including clear objectives, methods, results, and discussions). Length: Typically 3,000–6,000 words (excluding abstract, references, tables, and figures). Structure: Include Title, Abstract (200–300 words, with 3–5 keywords), Introduction, Methods, Results, Discussion, Conclusion, References, and Author Contributions. 2.2 Review Articles Content: Synthesize the latest research progress in a specific subfield, identify research gaps, and propose future directions. Length: 4,000–8,000 words (excluding references and figures). Requirement: Must cite recent, high-impact literature (preferably within the past 5 years) and avoid simple summaries of existing studies. 2.3 Case Reports Content: Report rare or representative clinical cases related to preventive medicine (e.g., atypical disease prevention cases, successful intervention cases). Length: 1,500–3,000 words. Requirement: Include Case Presentation, Discussion (linking the case to broader preventive medicine implications), and Ethics Statement (if involving human subjects). 2.4 Viewpoints/Commentaries Content: Express insights on hot topics, policy issues, or emerging trends in preventive medicine (supported by evidence or logical analysis). Length: 1,000–2,000 words. Requirement: Clear stance, concise argumentation, and no redundant background information. 3. Submission Preparation 3.1 Formatting Standards Language: Manuscripts must be written in English (American or British English consistently; avoid mixing). Font & Spacing: Use 12-point Times New Roman font, 1.5-line spacing, and 1-inch margins on all sides. Citations & References: Follow the Vancouver Style (numerical in-text citations corresponding to a numbered reference list). Use reliable sources (e.g., peer-reviewed journals, official reports) and ensure all citations are accurate and complete. Example: [1] World Health Organization. Global Health Estimates 2023: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2023. Geneva: WHO; 2023. Tables & Figures: Label tables as “Table 1, Table 2…” and figures as “Figure 1, Figure 2…” (with descriptive captions). Ensure figures are high-resolution (minimum 300 dpi) and in editable formats (e.g., PNG, TIFF, or Excel for tables). Avoid duplicating data between tables and text. 3.2 Ethical Compliance Human/Animal Subjects: If the research involves human participants or animals, the manuscript must include: A statement confirming approval by the relevant Institutional Review Board (IRB) or Ethics Committee (e.g., “This study was approved by the Ethics Committee of [Institution Name], Approval No. [XXX]”). A statement confirming informed consent was obtained from all participants (or their legal guardians for minors). Conflict of Interest (COI): All authors must complete and submit a Conflict of Interest Declaration Form. If no conflicts exist, state: “All authors declare no competing interests.” Originality: Manuscripts must be original and not previously published (including in preprint servers like arXiv or bioRxiv, unless explicitly noted and updated). Simultaneous submission to other journals is strictly prohibited. 4. Submission Process 4.1 Submission Channels Choose one of the following official channels (do not submit via multiple channels): Online Submission System: Log in to the FPMJ platform (https://fpmjournal.org/) and navigate to the “FPM Submission” section to upload your manuscript and supplementary materials. Email Submission: Send the complete manuscript (as a single PDF file) and supplementary documents (e.g., COI form, IRB approval letter) to the editorial office: info@fpmjournal.org. Email subject format: “FPM Submission – [Manuscript Title] – [Corresponding Author Name]”. 4.2 Required Documents The complete manuscript (PDF format, with all tables/figures embedded). Conflict of Interest Declaration Form (signed by all authors). IRB/Ethics Committee approval letter (if applicable). Permission letters (if using copyrighted materials, e.g., figures from other journals). Contact information of the corresponding author (full name, affiliation, email, and phone number). 5. Peer Review Process Initial Screening: The editorial office will first check if the manuscript meets FPM’s scope, format, and ethical requirements. Manuscripts that fail initial screening will be rejected without peer review. Peer Review: Qualified manuscripts will be sent to 2–3 independent reviewers (experts in the relevant field). The review process typically takes 4–6 weeks. Decision Notification: After reviewing reviewer comments, the editor-in-chief will make one of the following decisions: Accept: No revisions needed. Minor Revision: Revisions required (reviewer comments addressed; no re-review needed). Major Revision: Substantial revisions required (re-review by original reviewers). Reject: Manuscript does not meet FPM’s academic standards. Revision Submission: Authors must respond to all reviewer comments (point-by-point) and submit revised manuscripts within the deadline specified in the decision letter. 6. Publication Fees & Rights Article Processing Charge (APC): To support academic accessibility, APC is fully waived for all manuscripts submitted by December 2026. No hidden fees will be charged during submission, review, or publication. Copyright: Upon acceptance, authors will sign a Copyright Transfer Agreement (CTA) granting FPM the right to publish, distribute, and archive the article. Authors retain the right to use the article for non-commercial purposes (e.g., teaching, personal research). Open Access: All articles published in FPM are available open access via the journal’s official platform and Crossref. Each article will be assigned a unique DOI (Digital Object Identifier) for global retrieval and citation. 7. Post-Publication Policies Errata/Corrections: If errors are identified after publication, authors must notify the editorial office promptly. The journal will publish an “Erratum” or “Correction” to correct the error. Retractions: Manuscripts may be retracted if they contain severe errors, plagiarism, or ethical misconduct (following guidelines from the Committee on Publication Ethics, COPE). 8. Contact & Support For questions about manuscript preparation, submission, or review, please contact the editorial office: Official Email: info@fpmjournal.org FPMJ Platform (for form downloads and updates): https://fpmjournal.org/ We look forward to receiving your high-quality submissions and supporting your contribution to the field of preventive medicine! Editorial Office of Frontiers in Preventive Medicine Public Health Young Scholars Alliance (PHYSA) October 31, 2025
1. Peer Review Model Frontiers in Preventive Medicine employs a Double-Anonymous Peer Review process to ensure impartiality and fairness. This means that: The identities of the authors are concealed from the reviewers. The identities of the reviewers are concealed from the authors. Both parties remain anonymous to each other throughout the review process. 2. Review Process Workflow The review process for each submitted manuscript follows these key stages: Initial Editorial Check: The Editor-in-Chief or Managing Editor performs an initial quality check for scope, formatting, plagiarism, and overall suitability. Assignment to Associate Editor: If the manuscript passes the initial check, it is assigned to an Associate Editor (a subject-area expert) who manages the subsequent peer review. Invitation to Reviewers: The Associate Editor invites at least two independent and qualified experts to review the manuscript. Review Period: Reviewers are given a specific timeframe to evaluate the manuscript based on originality, significance, methodology, clarity, and adherence to ethical standards. Decision Recommendation: Reviewers submit their reports with a recommendation (Accept, Minor Revision, Major Revision, or Reject). Editorial Decision: The Associate Editor, considering the reviewers' comments, makes a final decision which is communicated to the corresponding author by the Editor-in-Chief. 3. Criteria for Review Reviewers are asked to evaluate manuscripts on the following criteria: Originality and Novelty Methodological Soundness and statistical validity Scholarly Significance and relevance to the field of preventive medicine Clarity of Presentation and logical structure Ethical Compliance in research conduct and reporting Adequacy of References 4. Revision Process Manuscripts that require revision will be returned to the authors. Authors are expected to submit a revised version along with a point-by-point response to the reviewers' comments. The revised manuscript may be sent back to the original reviewers for re-evaluation. 5. Confidentiality and Ethics All individuals involved in the review process—editors and reviewers—must treat submitted manuscripts as confidential documents. They must not disclose any information about the manuscript during or after the review process to anyone other than the editorial team. Our peer review process adheres to the guidelines and standards set by the Committee on Publication Ethics (COPE).
Frontiers in Preventive Medicine is committed to upholding the highest standards of publication ethics and takes all forms of malpractice seriously. Our policy is based on the guidelines and standards set by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the World Association of Medical Editors (WAME). 1. Duties and Responsibilities of Editors Decision-Making: The Editor-in-Chief is responsible for the final decision on the publication of submitted manuscripts. This decision will be based on the manuscript's validation, importance, and clarity, and guided by the policies of the journal's editorial board, without regard to the authors' race, gender, sexual orientation, ethnic origin, citizenship, religious belief, political philosophy, or institutional affiliation. Confidentiality: Editors and editorial staff must hold all information about a submitted manuscript in strict confidence. They must not disclose any information to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate. Fair Play: Editors will evaluate manuscripts for their intellectual content without regard to the nature of the authors. Disclosure and Conflicts of Interest: Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author. Editors will recuse themselves from considering manuscripts in which they have conflicts of interest. 2. Duties and Responsibilities of Reviewers Contribution to Editorial Decisions: Peer review assists the editor in making editorial decisions and, through the editorial communications with the author, may also assist the author in improving the manuscript. Promptness: Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse themselves from the review process. Confidentiality: Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor. Standards of Objectivity: Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments. Acknowledgment of Sources: Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. Disclosure and Conflict of Interest: Reviewers must not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers. 3. Duties and Responsibilities of Authors Reporting Standards: Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Data Access and Retention: Authors may be asked to provide the raw data in connection with a paper for editorial review and should be prepared to provide public access to such data, if practicable, and should in any event be prepared to retain such data for a reasonable time after publication. Originality and Plagiarism: Authors must ensure that they have written entirely original works. The work and/or words of others must be appropriately cited or quoted. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Multiple, Redundant, or Concurrent Publication: An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. Acknowledgment of Sources: Proper acknowledgment of the work of others must always be given. Authorship of the Paper: Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. The corresponding author ensures that all contributing co-authors are included in the author list. Disclosure and Conflicts of Interest: All authors should disclose in their manuscript any financial or other substantive conflicts of interest that might be construed to influence the results or their interpretation in the manuscript. Fundamental Errors in Published Works: When an author discovers a significant error or inaccuracy in their own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with them to retract or correct the paper. 4. Publisher’s Duties Handling of Unethical Publishing Behavior: In cases of alleged or proven scientific misconduct, fraudulent publication, or plagiarism, the publisher, in close collaboration with the editors, will take all appropriate measures to clarify the situation and to amend the article in question. This includes the prompt publication of an erratum, clarification, or, in the most severe cases, the retraction of the work. Access to Journal Content: The publisher is committed to the permanent availability and preservation of scholarly research and ensures accessibility by partnering with organizations and maintaining our own digital archive.
Policy on Handling Post-Publication Issues
Frontiers in Preventive Medicine is committed to upholding the integrity of the scholarly record. We recognize a responsibility to correct the record when necessary and to be transparent about any serious concerns. This policy outlines our procedures for handling post-publication issues, in accordance with the best practices and flowcharts provided by the Committee on Publication Ethics (COPE). 1. Corrections (Erratum) Purpose: An Erratum is published to correct a significant error(s) in a published article that affects the scientific integrity, the publication record, or the reputation of the authors or the journal, but where the scholarly findings as a whole remain valid and reliable. Grounds for Issuance: An error in data or calculations that does not alter the main conclusions. Errors in authorship (e.g., an missing or misspelled author name). Errors in the acknowledgment or funding statement. Other factual errors that require clarification. Process: Identification: Errors can be identified by the authors, readers, reviewers, or editors. Assessment: The editorial office, in consultation with the corresponding author and if necessary, subject experts, assesses the impact of the error. Decision: If the error is deemed significant, a decision to publish a Correction is made. Publication: The Correction is published as a separate, citable article with its own DOI, clearly linked bidirectionally to the original article. A prominent notice is also added to the original article's HTML and PDF versions, alerting readers to the existence of the Correction. 2. Retractions Purpose: A Retraction is issued to remove a published article from the scholarly record when the findings are deemed unreliable due to major error or misconduct, or in cases of redundant publication, plagiarism, or unethical research. Grounds for Issuance: Clear evidence of unreliable data or findings, whether as a result of misconduct (e.g., data fabrication) or honest error (e.g., miscalculation). Plagiarism or redundant publication. Unethical research conduct. Legal/defamatory content or privacy violations. Process: Investigation: Upon receiving an allegation, the Editor-in-Chief initiates an investigation. This may involve contacting the authors' institution(s). Notification: The corresponding author is informed of the allegation and given an opportunity to respond. Decision: The final decision to retract is made by the Editor-in-Chief, based on conclusive evidence and potentially in consultation with the editorial board. The authors may be asked to agree to the retraction, but their agreement is not mandatory. Publication of Retraction Notice: The Retraction Notice is published as a separate, citable article, clearly stating the reason for retraction and who is retracting the article. The title of the original article is prefixed with "RETRACTED:" in all its forms (HTML and PDF). The Retraction Notice is bidirectionally linked to the original article. A prominent watermark may be added to the PDF. The original article remains accessible online to maintain the scholarly record, but is unequivocally marked as retracted. 3. Editorial Expressions of Concern Purpose: An Editorial Expression of Concern is issued to alert the readership to serious, but as yet unresolved, concerns about the integrity of a published article. It is used when an investigation is ongoing and a final conclusion has not been reached. Grounds for Issuance: Inconclusive evidence of authorship or research misconduct. Belief that an institutional investigation into alleged misconduct related to the publication is underway but has not been, or will not be, concluded for a considerable time. The editors believe the findings are unreliable, but the authors' institution will not investigate the case. Process: Assessment: The Editor-in-Chief assesses whether the concerns are serious enough that the academic community should be alerted while awaiting a final resolution. Publication: An Editorial Expression of Concern is published as a citable notice, linked to the original article. It explains the nature of the concerns clearly and objectively. Resolution: Once a final determination is made, the Expression of Concern is replaced by either a formal Retraction Notice, a Correction, or a notification that the concerns have been resolved. 4. Overarching Principles Transparency: All notices will be freely accessible and explicitly state the reason for the action. Timeliness: Actions will be taken as promptly as possible to minimize the impact of unreliable information. Fairness: Authors will be given the opportunity to respond to any allegations at all stages of the process. Consistency: Decisions will be guided by the COPE guidelines and flowcharts. To report a potential error or concern regarding a published article, please contact the editorial office at editorial@fpmjournal.org.
Frontiers in Preventive Medicine is committed to the ethical principles of research involving human participants as outlined in the Declaration of Helsinki. This policy mandates that all manuscripts reporting such research must contain a statement confirming that informed consent was obtained from all participants or their legally authorized representatives. 1. Core Principle Research involving human participants must be conducted in accordance with all applicable international, national, and institutional guidelines. The welfare and rights of the participants are paramount. A fundamental component of this ethical obligation is the procurement of voluntary, informed consent. 2. Requirements for Informed Consent 2.1. Process of Obtaining Consent: Consent must be obtained prior to the participant's involvement in the research. The consent process must be informed, meaning that the participant must be provided with clear and comprehensible information about the study. This information must include, but is not limited to: The nature and purpose of the research. The procedures involved, including the time commitment. Any potential risks, discomforts, or benefits. The right to withdraw from the study at any time without penalty. Measures taken to ensure confidentiality of data. Whom to contact for answers to pertinent questions about the research. Consent must be voluntary and free from any form of coercion or undue influence. For research involving children or participants who are unable to give consent, consent must be obtained from a parent, guardian, or legally authorized representative. 2.2. Documentation of Consent: Authors must be prepared to provide documentation of ethical approval and consent procedures upon request by the editors. Consent must be documented in writing. A signed consent form is the standard and expected method of documentation. 3. Exceptions to Written Consent In certain specific circumstances, the requirement for written consent may be waived by an Ethics Board or Institutional Review Board (IRB). This is typically considered for: Minimal risk research where a signed consent form would be the only record linking the participant to the study, thereby posing a primary risk to confidentiality (e.g., sensitive surveys). Research where consent is implied by the action of participation (e.g., completion of an anonymous online questionnaire), provided this is explicitly approved by the relevant ethics committee. In such cases, the manuscript must include a statement detailing the reason for the waiver and confirming that the waiver was granted by the overseeing ethics committee. 4. Manuscript Submission Requirements All manuscripts reporting research involving human participants must include a statement within the "Methods" or "Ethics" section that confirms: That informed consent was obtained from all participants. That the study was approved by an appropriate Ethics Committee or Institutional Review Board (IRB), including the name of the board and the reference number of the approval. The methods used to obtain consent (e.g., "written informed consent was obtained from all participants"). Example Statement for Manuscripts: "This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of [Institution Name] (Approval No. [IRB Number]). Written informed consent was obtained from all individual participants involved in the study." 5. Privacy and Confidentiality Authors must protect the anonymity and privacy of research participants. Identifying details (e.g., names, initials, addresses, specific dates, hospital numbers) should not be published in written descriptions, photographs, or genetic profiles unless the information is essential for scientific purposes and the participant (or legal representative) has provided written informed consent for publication. If identifying information is necessary, authors must declare in the manuscript that they have obtained specific consent for its publication. 6. Non-Compliance Manuscripts that fail to include the required ethical statements or that, upon investigation, are found to have violated ethical standards of informed consent will be rejected or, if already published, will be subject to retraction.
Frontiers in Preventive Medicine maintains the highest standards of editorial independence and integrity. The publication of advertisements is solely a means of generating revenue and does not imply endorsement by the Journal, its Editors, or the Public Health Young Scholars Alliance. 1. General Principles Separation of Content: Advertising must be easily distinguishable from editorial content. All advertisements will be clearly labeled as "Advertisement." Editorial Independence: The acceptance or rejection of an advertisement will not influence the editorial decision-making process for any manuscript. Advertisers will have no prior knowledge of or influence over the journal's content. Liability: The advertiser is solely responsible for the content of the advertisement, including any claims made therein. The Journal reserves the right to reject, cancel, or request modifications to any advertisement at any time. 2. Eligibility and Content Guidelines The Journal reserves the right to accept or decline any advertisement. Advertisements are subject to approval and must comply with the following guidelines: Acceptable Advertisements may include: Scholarly or professional conferences, meetings, and workshops. Academic and professional books or journals. Laboratory equipment, software, and services relevant to the fields of preventive medicine and public health. Educational and professional development opportunities. Relevant philanthropic or non-commercial initiatives. Prohibited Advertisements include, but are not limited to: Content that is misleading, fraudulent, defamatory, or offensive. Political or religious advocacy. Products such as tobacco, firearms, and alcoholic beverages. Advertisements that constitute personal attacks or are in poor scientific taste. Content that infringes upon the intellectual property rights of others. Advertisements that are not appropriate for the journal's professional audience. 3. Placement and Design Advertisements will not be placed on or within the PDF version of any specific article in a manner that suggests a direct endorsement by the authors of that article. Advertisements will not be integrated into the editorial content in a way that compromises its integrity. The use of the Journal's logo or name in an advertisement is prohibited without prior written consent. 4. Digital Advertising The Journal may use third-party advertising networks to serve digital advertisements. While the Journal will make reasonable efforts to ensure compliance, it is not responsible for the content of advertisements served by these third parties. The Journal complies with applicable data privacy laws. For more information, please see our Privacy Statement. 5. Policy Updates Frontiers in Preventive Medicine reserves the right to modify this Advertising Policy at any time. Any changes will be posted on this page. For advertising inquiries, please contact: info@fpmjournal.org
Dear Authors, Reviewers, Editorial Board Members, and Readers, We are pleased to announce an important update: effective immediately, Frontiers in Preventive Medicine has been officially renamed Journal of Public Health and Preventive Medicine. This strategic change reflects our evolving vision to better define the journal's scope, expand its academic influence, and more effectively serve scholars and practitioners in the global public health and preventive medicine communities. Background and Vision Since its launch, our journal has been dedicated to providing a high-level, interdisciplinary platform for disseminating cutting-edge research in preventive medicine and public health. As the field evolves and global health challenges become increasingly complex, the integration of public health and preventive medicine has never been more critical. The new title more accurately captures our core mission: to bridge the gap between fundamental research, clinical practice, community action, and policy implementation, ultimately advancing health promotion and disease prevention for populations worldwide. Under its new name, the journal will continue to uphold rigorous peer review and our open access publishing model, while further expanding its scope to encompass a broad spectrum of topics, including epidemiology, chronic disease prevention, infectious disease surveillance, vaccinology, health equity, environmental and occupational health, health behavior, digital health, health economics, and global health. Key Information Update New Journal Title: Journal of Public Health and Preventive Medicine ISSN: The existing ISSN (online) will remain unchanged Publisher: Public Health Young Scholars Alliance Official Website: [www.jphpm.fpmjournal.org] (The previous domain will automatically redirect) Submission System: All submission procedures, formatting guidelines, and review criteria remain the same. Manuscripts currently under review will be processed without interruption. Our Commitment Remains Unchanged A new name is just the beginning. Our dedication to academic excellence, author service, and open science remains steadfast: ✅ Rigorous Peer Review: Maintaining double-blind review to ensure fairness, integrity, and scientific validity ✅ Open Access: All articles are freely available to read, download, and share, maximizing research visibility and impact ✅ Rapid Publication: Streamlined editorial processes to ensure timely dissemination of critical findings ✅ Interdisciplinary Engagement: Fostering dialogue and collaboration across research, clinical practice, policy, and community health Gratitude and Looking Forward We extend our deepest gratitude to every author, reviewer, editorial board member, and reader who has supported us along this journey. Your trust and contributions have shaped the journal into what it is today. As we move forward, Journal of Public Health and Preventive Medicine will continue to respond to the evolving needs of public health and preventive medicine with high-quality, impactful scholarship. We warmly invite you to continue supporting the journal—by submitting your research, volunteering as a reviewer, and recommending us to your colleagues. Together, let us contribute to a healthier and more equitable world. For any inquiries, please feel free to contact our editorial office: [editorial@fpmjournal.org] Editorial Office Journal of Public Health and Preventive Medicine February 2026